- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03168126
Advanced Hemodynamic Monitoring in Free Flap Surgery (AHM)
Background: Anesthesia in free flap surgery is challenging. Monitoring of hemodynamic changes and their influence on the cardiovascular system in permanent feedback loops allow control, which is what anesthesiologists aim for to ensure an adequate blood flow and tissue oxygenation. The circulatory support and inferable volume administration are managed via heart rate (HR) and mean arterial pressure (MAP), but both parameters are influenced by variable components and are thus unfavorable for volume management. The aim of this study was to evaluate whether volume requirement may be assumable to additional monitoring parameters.
Methods: 31 patients were enrolled prospectively. HR, MAP, central venous pressure and O2 saturation were comprehended based on the protocols. We expanded the data set by a permanent blinded intraoperative monitoring with registration of the Cardiac Index (CI) and Stroke Volume Variation (SVV) and semi-invasive pulse-contour analysis utilizing the Pro-AQT-Device.
Study Overview
Status
Intervention / Treatment
Detailed Description
We conducted a prospective cohort study in accordance with the WMA Declaration of Helsinki. Standard general anesthesia with intubation and administration of sufentanil, propofol and esmeron relaxant was performed in all patients undergoing primary free flap reconstruction in course of a head and neck tumor reconstruction. Hemodynamic monitoring measurement of cardiac index and the parameter stroke volume variation as surrogate for cardiac pre-load was performed using a Pro-AQT Monitor. Using an arterial catheter previously set by the Seldinger technique as part of the standard equipment, the mean, diastolic and systolic arterial pressure was measured as part of the standard monitoring as presented. This tube was previously deaerated and flushed with 2% NaCl and connected in series with a sensor, which passes over electric line signals to the Pro-AQT-Monitor®. Based on previously entered patient data and an analysis of the arterial pulse curve characteristics, a cardiac index (CI) start-value is determined by the system. The sampling of the arterial pressure characteristics is affected by a signal having a frequency of 250 Hz. The start value is the basis for the further determination of HI trend values. The arterial pulse contour is continuously tapped and analyzed and offset against the determined start value. To calculate the cardiac index, the PICCO®-pulse contour algorithm is applied. Every 12 seconds, a new measurement is performed and documented by the system.
From the read logs ProAQT Monitor® the values of the CI, MAP, HR, stroke volume index (SVI), the stroke volume variation (SVV) and the systemic resistance index (SRI) were recorded at different measurement intervals throughout the operation. All parameters were evaluated for volume control in the course of the study.
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- 18 years of age, free flap surgery, oral squamous cell carcinoma, informed consent
Exclusion Criteria:
- <18 years of age, no informed consent
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Pro-AQT-Monitoting
Patients with OSCC of the jaws and tumor resection + primary free flap reconstruction
|
Use of the device for advanced hemodynamic monitoring
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Stroke Volume Variance (SVV)
Time Frame: during the surgical intervention
|
during the surgical intervention
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Mean arterial pressure
Time Frame: during the surgical intervention
|
during the surgical intervention
|
|
heart rate
Time Frame: during the surgical intervention
|
during the surgical intervention
|
|
cardiac index
Time Frame: during the surgical intervention
|
during the surgical intervention
|
|
standard resistance index
Time Frame: during the surgical intervention
|
during the surgical intervention
|
Collaborators and Investigators
Investigators
- Principal Investigator: Johannes Wikner, MD DMD, Universitätsklinikum Hamburg-Eppendorf
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 002 (University of CT Health Center)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fluid Overload
-
Nordsjaellands HospitalRigshospitalet, Denmark; University of CopenhagenRecruitingFluid Therapy | Fluid Overload | Fluid AccumulationSpain, Denmark, India, United Kingdom, Finland, Iceland, Lithuania, New Zealand, Norway, Sweden, Switzerland
-
Jagiellonian UniversityCompletedFluid Overload | Fluid LossPoland
-
Uppsala UniversityCompletedFluid Therapy | Fluid Overload | Critical CareSweden
-
Nuwellis, Inc.AKI Critical Care Research FoundationTerminatedFluid OverloadUnited States
-
Hospices Civils de LyonRecruiting
-
Morten H. BestleUniversity of Copenhagen; Copenhagen Trial Unit, Center for Clinical Intervention... and other collaboratorsRecruitingFluid OverloadDenmark, Netherlands, Switzerland, Finland, Iceland, Norway, Australia
-
Nova Scotia Health AuthorityWithdrawnFluid OverloadCanada
-
All India Institute of Medical Sciences, RishikeshCompleted
-
Medical University of ViennaCompleted
Clinical Trials on Pro-AQT
-
The University of Texas Medical Branch, GalvestonCompletedDiet | Protein | Skeletal MuscleUnited States
-
Cairo UniversityUnknown
-
Abramson Cancer Center at Penn MedicineNational Cancer Institute (NCI)Completed
-
CytoDyn, Inc.WEP ClinicalAvailableTNBC, Triple Negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | TNBCUnited States
-
United States Army Research Institute of Environmental...Eastern Michigan UniversityCompletedWeight Loss | Other Effects of High AltitudeUnited States
-
North Florida Foundation for Research and EducationPfizer; US Department of Veterans AffairsUnknownRheumatoid ArthritisUnited States
-
Bolton MedicalActive, not recruitingAortic Dissection Type BUnited States
-
University Health Network, TorontoPatient-Centered Outcomes Research Institute; M.D. Anderson Cancer Center; Applied... and other collaboratorsCompletedDysphagiaUnited States, Canada
-
University of AarhusAarhus University Hospital; TrygFonden, Denmark; Sygekassernes Helsefond; Regional... and other collaboratorsCompletedChronic Kidney DiseasesDenmark
-
Zhejiang UniversitySecond Affiliated Hospital of Nanchang University; Lishui Municipal Central...Recruiting